Find your distribution partner
The world map provides an overview of the countries where ABX is represented as a Marketing Authorization Holder (MAH), as well as markets with authorisations by our partners. Relevant contact details are provided for all the countries shown to facilitate direct inquiries regarding product availability, authorization status, or further information.
- MAH ABX - CMO Partner
- MAH Local Partner
- MAH ABX - CMO Partner
- MAH Local Partner
Download SmPC and Educational Material
Austria
Austria
Summary of product characteristics (SmPC):
↓ 1300 MBq/ml solution for injection
↓ 2000 MBq/ml solution for injection
↓ Educational Material for Healthcare Professionals
Package leaflet:
↓ 1300 MBq/ml solution for injection
↓ 2000 MBq/ml solution for injection
↓ 1300 MBq/ml solution for injection
↓ 2000 MBq/ml solution for injection
↓ Educational Material for Healthcare Professionals
Package leaflet:
↓ 1300 MBq/ml solution for injection
↓ 2000 MBq/ml solution for injection
Belgium
Belgium
Summary of product characteristics (SmPC):
↓ 1300 MBq/ml solution for injection
↓ 2000 MBq/ml solution for injection
↓ Educational Material for Healthcare Professionals
Package leaflet:
↓ 1300 MBq/ml solution for injection
↓ 2000 MBq/ml solution for injection
↓ 1300 MBq/ml solution for injection
↓ 2000 MBq/ml solution for injection
↓ Educational Material for Healthcare Professionals
Package leaflet:
↓ 1300 MBq/ml solution for injection
↓ 2000 MBq/ml solution for injection
France
France
Summary of product characteristics (SmPC):
↓ 1300 MBq/ml solution for injection
↓ 2000 MBq/ml solution for injection
Package leaflet:
↓ 1300 MBq/ml solution for injection
↓ 2000 MBq/ml solution for injection
↓ 1300 MBq/ml solution for injection
↓ 2000 MBq/ml solution for injection
Package leaflet:
↓ 1300 MBq/ml solution for injection
↓ 2000 MBq/ml solution for injection
Germany
Germany
Summary of product characteristics (SmPC):
↓ 1300 MBq/ml solution for injection
↓ 2000 MBq/ml solution for injection
↓ Educational Material for Healthcare Professionals
Package leaflet:
↓ 1300 MBq/ml solution for injection
↓ 2000 MBq/ml solution for injection
↓ 1300 MBq/ml solution for injection
↓ 2000 MBq/ml solution for injection
↓ Educational Material for Healthcare Professionals
Package leaflet:
↓ 1300 MBq/ml solution for injection
↓ 2000 MBq/ml solution for injection
Italy
Italy
Summary of product characteristics (SmPC):
↓ 1300 MBq/ml solution for injection
↓ 2000 MBq/ml solution for injection
↓ Educational Material for Healthcare Professionals
Package leaflet:
↓ 1300 MBq/ml solution for injection
↓ 2000 MBq/ml solution for injection
↓ 1300 MBq/ml solution for injection
↓ 2000 MBq/ml solution for injection
↓ Educational Material for Healthcare Professionals
Package leaflet:
↓ 1300 MBq/ml solution for injection
↓ 2000 MBq/ml solution for injection
Luxembourg
Luxembourg
Summary of product characteristics (SmPC):
↓ 1300 MBq/ml solution for injection
↓ 2000 MBq/ml solution for injection
↓ Educational Material for Healthcare Professionals
Package leaflet:
↓ 1300 MBq/ml solution for injection
↓ 2000 MBq/ml solution for injection
↓ 1300 MBq/ml solution for injection
↓ 2000 MBq/ml solution for injection
↓ Educational Material for Healthcare Professionals
Package leaflet:
↓ 1300 MBq/ml solution for injection
↓ 2000 MBq/ml solution for injection
Poland
Poland
Summary of product characteristics (SmPC):
↓ 1300 MBq/ml solution for injection
↓ 2000 MBq/ml solution for injection
↓ Educational Material for Healthcare Professionals
Package leaflet:
↓ 1300 MBq/ml solution for injection
↓ 2000 MBq/ml solution for injection
↓ 1300 MBq/ml solution for injection
↓ 2000 MBq/ml solution for injection
↓ Educational Material for Healthcare Professionals
Package leaflet:
↓ 1300 MBq/ml solution for injection
↓ 2000 MBq/ml solution for injection
Portugal
Portugal
Summary of product characteristics (SmPC)
↓ 1300 MBq/ml solution for injection
↓ 2000 MBq/ml solution for injection
↓ Educational Material for Healthcare Professionals (available on the INFOMED website)
Package leaflet:
↓ 1300 MBq/ml solution for injection
↓ 2000 MBq/ml solution for injection
↓ 1300 MBq/ml solution for injection
↓ 2000 MBq/ml solution for injection
↓ Educational Material for Healthcare Professionals (available on the INFOMED website)
Package leaflet:
↓ 1300 MBq/ml solution for injection
↓ 2000 MBq/ml solution for injection
Spain
Spain
Summary of product characteristics (SmPC)
▼ Radelumin (PSMA-1007 (¹⁸F)):
↓ 1300 MBq/ml solution for injection and/ or
↓ 2000 MBq/ml solution for injection
↓ Educational Material for Healthcare Professionals
Consult this material alongside the medicinal product's summary of product characteristics, available via the AEMPS online medicines information center (CIMA). https://cima.aemps.es/
It is important to remember to report suspected adverse reactions through the corresponding Regional Pharmacovigilance Centre or the electronic form available at https://www.notificaRAM.es
Risk prevention information agreed upon with the Spanish Agency of Medicines and Medical Devices (AEMPS). April 2024.
▼ This medicinal product is subject to additional monitoring; reporting suspected adverse reactions associated with this medicinal product is a priority.
Package leaflet:
↓ 1300 MBq/ml solution for injection
↓ 2000 MBq/ml solution for injection
▼ Radelumin (PSMA-1007 (¹⁸F)):
↓ 1300 MBq/ml solution for injection and/ or
↓ 2000 MBq/ml solution for injection
↓ Educational Material for Healthcare Professionals
Consult this material alongside the medicinal product's summary of product characteristics, available via the AEMPS online medicines information center (CIMA). https://cima.aemps.es/
It is important to remember to report suspected adverse reactions through the corresponding Regional Pharmacovigilance Centre or the electronic form available at https://www.notificaRAM.es
Risk prevention information agreed upon with the Spanish Agency of Medicines and Medical Devices (AEMPS). April 2024.
▼ This medicinal product is subject to additional monitoring; reporting suspected adverse reactions associated with this medicinal product is a priority.
Package leaflet:
↓ 1300 MBq/ml solution for injection
↓ 2000 MBq/ml solution for injection
Netherlands
Netherlands
Summary of product characteristics (SmPC):
↓ 1300 MBq/ml solution for injection
↓ 2000 MBq/ml solution for injection
↓ Educational Material for Healthcare Professionals
Package leaflet:
↓ 1300 MBq/ml solution for injection
↓ 2000 MBq/ml solution for injection
↓ 1300 MBq/ml solution for injection
↓ 2000 MBq/ml solution for injection
↓ Educational Material for Healthcare Professionals
Package leaflet:
↓ 1300 MBq/ml solution for injection
↓ 2000 MBq/ml solution for injection
United Kingdom
United Kingdom
Summary of product characteristics (SmPC):
↓ 2000 MBq/ml solution for injection
↓ Educational Material for Healthcare Professionals
Package leaflet:
↓ 2000 MBq/ml solution for injection
↓ 2000 MBq/ml solution for injection
↓ Educational Material for Healthcare Professionals
Package leaflet:
↓ 2000 MBq/ml solution for injection